Last reviewed · How we verify
aIIV4
At a glance
| Generic name | aIIV4 |
|---|---|
| Sponsor | Seqirus |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Influenza Vaccination Strategy for Patients With Hematologic Malignancy (PHASE3)
- Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines (NA)
- Simultaneous RZV and aIIV4 Vaccination (PHASE4)
- Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults (PHASE2)
- Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |